Variant report
Variant | esv3362498 |
---|---|
Chromosome Location | chr4:151577852-151579950 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551742083 | chr4:151577857-151577858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550152924 | chr4:151577867-151577868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150197747 | chr4:151577876-151577877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183549145 | chr4:151577883-151577884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569198602 | chr4:151577890-151577891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138778572 | chr4:151577934-151577935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141654490 | chr4:151577942-151577943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369660220 | chr4:151577944-151577945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74515055 | chr4:151577950-151577951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187896430 | chr4:151578018-151578019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538298727 | chr4:151578029-151578030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138472903 | chr4:151578036-151578037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571875072 | chr4:151578051-151578052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534481684 | chr4:151578115-151578116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566639796 | chr4:151578189-151578190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374791917 | chr4:151578222-151578223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533699594 | chr4:151578228-151578229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554424039 | chr4:151578328-151578329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192374187 | chr4:151578337-151578338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558608667 | chr4:151578348-151578349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183845610 | chr4:151578350-151578351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144018939 | chr4:151578360-151578361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs61516869 | chr4:151578393-151578394 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs545096657 | chr4:151578394-151578395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565264959 | chr4:151578429-151578430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs527594651 | chr4:151578467-151578468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540897475 | chr4:151578508-151578509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74679506 | chr4:151578537-151578538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11099773 | chr4:151578579-151578580 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs189052896 | chr4:151578660-151578661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555923259 | chr4:151578706-151578707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377030144 | chr4:151578707-151578708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532215191 | chr4:151578711-151578712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555709596 | chr4:151578733-151578734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192965986 | chr4:151578735-151578736 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113864296 | chr4:151578744-151578745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs62346260 | chr4:151578754-151578755 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs534520430 | chr4:151578765-151578766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148380551 | chr4:151578777-151578778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534221797 | chr4:151578861-151578862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141613633 | chr4:151578883-151578884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536892124 | chr4:151578952-151578953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184682477 | chr4:151578969-151578970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576494772 | chr4:151579009-151579010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190397868 | chr4:151579107-151579108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs4270570 | chr4:151579165-151579166 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs572059952 | chr4:151579203-151579204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112101707 | chr4:151579217-151579218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181548172 | chr4:151579239-151579240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567307991 | chr4:151579248-151579249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 17588203 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:151487200-151655000 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
2 | chr4:151533400-151596200 | Weak transcription | Primary hematopoietic stem cells | blood |
3 | chr4:151554800-151585200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:151555800-151585600 | Weak transcription | Primary B cells from cord blood | blood |
5 | chr4:151559400-151578200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr4:151571200-151601600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
7 | chr4:151571200-151604600 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
8 | chr4:151573200-151583800 | Weak transcription | Lung | lung |
9 | chr4:151574800-151601200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
10 | chr4:151575800-151581400 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
11 | chr4:151576600-151585600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr4:151577200-151582400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr4:151577600-151637000 | Weak transcription | Primary T cells from cord blood | blood |
14 | chr4:151578000-151578800 | Enhancers | HUVEC | blood vessel |
15 | chr4:151578200-151578600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr4:151578400-151578600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr4:151578600-151582200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
18 | chr4:151578600-151589600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr4:151579400-151604400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |